Clinical Trial Update: Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing whether cholesterol-lowering therapy can prevent silent cerebrovascular lesions and cognitive decline in elderly patients with at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Radboud University Medical Center | Conditions: Atrial Fibrillation, Neuropsychology | Phase 4 | Status: COMPLETED